Report #2835184

Received Apr 9, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: PA
Recovered: Unknown
Vaccinated: Mar 26, 2025
Onset: Mar 26, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEP	HEP B (ENGERIX-B)	GLAXOSMITHKLINE BIOLOGICALS	UNK	EP724	—

Symptoms (1)

Expired product administered

Symptom narrative

the dose had expired on March 14th 2025; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 65-year-old female patient who received HBV (Engerix B) (batch number EP724, expiry date 14-MAR-2025) for prophylaxis. On 26-MAR-2025, the patient received Engerix B. On 26-MAR-2025, an unknown time after receiving Engerix B, the patient experienced expired vaccine used (Verbatim: the dose had expired on March 14th 2025). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date : 26-MAR-2025 Engerix B was administered on March 26th 2025 and the dose had expired on March 14th 2025 which led to expired vaccine used.